Loading data for LABU — first visit, this takes a few seconds.
Direxion Daily S&P Biotec... (LABU)
NYSEArca: LABU
· Real-Time Price · USD
309.60
+19.62 (6.77%)
At close: Aug 20, 2026, 4:04 PM
Direxion Daily S&P Biotech Bull 3X Shares (LABU) ETF Price, Holdings & Analysis
6.77% (1D)
No data available
| Bid | 336 |
| Market Cap | n/a |
| AUM | 494.37M |
| NAV | 290.08 |
| Beta | 3.26 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | n/a |
| Inception Date | May 28, 2015 |
| Ask | 339.6 |
| Volume | 711,371 |
| Avg. Volume (20D) | 518,719 |
| Open | 318.50 |
| Previous Close | 289.98 |
| Day's Range | 314.50 - 341.91 |
| 52-Week Range | 66.00 - 341.93 |
| Holdings | n/a |
| Expense Ratio | 0.96% |
About LABU
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Asset Class Equity
Ticker Symbol LABU
Inception Date May 28, 2015
Provider Direxion Funds
Website Fund Home Page
Exchange NYSEArca
Top 10 Holdings 3.23% of assets
| Name | Symbol | Weight |
|---|---|---|
| Apogee Therapeutics ... | APGE | 1.16% |
| Oruka Therapeutics I... | ORKA | 1.07% |
| Dianthus Therapeutic... | DNTH | 1.00% |
Dividends Dividend Yield 0.43%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 23, 2025 | $0.9100 | n/a |
| Sep 23, 2025 | $0.1030 | n/a |
| Jun 24, 2025 | $0.2190 | n/a |
| Mar 25, 2025 | $0.1070 | n/a |
| Jun 25, 2024 | $0.1500 | n/a |
